</s><s><s><s> human papillomavirus ( hpv ) vaccination of mid-adult women in the united states is an important public health issue. 
 the cost-effectiveness of hpv vaccination of men who have sex with men in the us is unknown, but is likely to be higher than the cost of male and female genital herpes virus ( hsv ) vaccination. in this report 
, we present a cost effectiv eness analysis of including boys and men in a vaccination programme against hsv, including the impact of vaccinating boys in the vaccinating population of the us. </s>